Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.

× No keyword cloud information.

18 in total

1. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.

Authors: Manjusha Malhotra; D K Majumdar
Journal: Indian J Exp Biol Date: 2002-05 Impact factor: 0.818

2. Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.

Authors: J W Sieg; J R Robinson
Journal: J Pharm Sci Date: 1975-06 Impact factor: 3.534

3. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

Authors: K D Solomon; J K Cheetham; R DeGryse; S F Brint; A Rosenthal
Journal: Ophthalmology Date: 2001-02 Impact factor: 12.079

4. An objective procedure for quantitating eye irritation based upon changes of corneal thickness.

Authors: H E Kennah; S Hignet; P E Laux; J D Dorko; C S Barrow
Journal: Fundam Appl Toxicol Date: 1989-02

5. Effects of calcium chelating agents on corneal permeability.

Authors: G M Grass; R W Wood; J R Robinson
Journal: Invest Ophthalmol Vis Sci Date: 1985-01 Impact factor: 4.799

6. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.

Authors: T L Ling; D L Combs
Journal: J Pharm Sci Date: 1987-04 Impact factor: 3.534

7. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.

Authors: A J Flach; M C Kraff; D R Sanders; L Tanenbaum
Journal: Arch Ophthalmol Date: 1988-04

8. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.

Authors: A J Flach; B J Dolan; A R Irvine
Journal: Am J Ophthalmol Date: 1987-04-15 Impact factor: 5.258

9. Use of flurbiprofen to inhibit corneal neovascularization.

Authors: C A Cooper; M V Bergamini; I H Leopold
Journal: Arch Ophthalmol Date: 1980-06

10. Effect of ketorolac on Candida albicans ocular infection in rabbits.

Authors: E B Fraser-Smith; T R Matthews
Journal: Arch Ophthalmol Date: 1987-02

5 in total

1. Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.

Authors: Manjusha Malhotra; Dipak K Majumdar
Journal: AAPS PharmSciTech Date: 2006 Impact factor: 3.246

Review 2. Topical ocular delivery of NSAIDs.

Authors: Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal: AAPS J Date: 2008-04-25 Impact factor: 4.009

3. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.

Authors: Tara Abdulrahman Abdullah; Naz Jamal Ibrahim; Musarrat Husain Warsi
Journal: Int J Pharm Investig Date: 2016 Apr-Jun

Review 4. Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors: Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal: J Ocul Pharmacol Ther Date: 2017-09-28 Impact factor: 2.671

5. Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application.

Authors: Anubha Khare; Inderbir Singh; Pravin Pawar; Kanchan Grover
Journal: J Drug Deliv Date: 2016-05-12

5 in total